Pulmonary Fibrosis Symptoms, Diagnosis, Prognosis and Treatment

August 16, 2017August 16, 2017
Pulmonary Fibrosis Foundation Plans Inaugural PFF Walk in Chicago to Honor PF Awareness Month
News
The Chicago-based Pulmonary Fibrosis Foundation (PFF) will hold its inaugural PFF Walk on Sept. 9 to mark PF Awareness Month. ... Read more
August 15, 2017August 15, 2017
IPF Catalyst Challenge Offers $1 Million Prize to Help Patients
Columns, Just Breathe...Compassionate Help for the PF Journey
I recently learned of a competition for innovators and entrepreneurs in the tech, healthcare, and scientific research communities to ... Read more
August 14, 2017August 11, 2017
Patient as Self-Advocate: It Seems Impossible to Keep Up
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
As a patient living with idiopathic pulmonary fibrosis (IPF), I am extremely grateful to the researchers, doctors, health advocates, ... Read more
August 14, 2017August 14, 2017
Galapagos Therapy GLPG1690 Excels in Phase 2 IPF Trial, Spurring Further Development
News
GLPG1690, an investigational therapy developed by Galapagos to treat idiopathic pulmonary fibrosis (IPF), prevented further lung decline in a Phase 2a ... Read more
August 11, 2017August 11, 2017
Experts Will Gather at Inaugural IPF Summit in Boston Aug. 21-23
News
Key leaders in the idiopathic pulmonary fibrosis therapy development industry, representing large pharma and biotech firms, academia and contract ... Read more
August 10, 2017August 9, 2017
Lung Disease and Transplantation: The Harsh Realities
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
In previous columns, I have alluded to the world of lung diseases and organ transplantation as one that is ... Read more
August 10, 2017August 10, 2017
FibroGen Shares Positive Results of Phase 2 Trial of Investigational Therapy Pamrevlumab
Esbriet, News
A Phase 2 trial testing the investigational therapy pamrevlumab (FG-3019) in patients with idiopathic pulmonary fibrosis (IPF) has shown positive ... Read more
August 9, 2017August 9, 2017
Three Lakes Partners Launches $1 Million ‘IPF Catalyst Challenge’ Competition
News
Three Lakes Partners, a venture philanthropy organization that finances research in idiopathic pulmonary fibrosis (IPF), has launched its $1 million IPF ... Read more
August 8, 2017August 8, 2017
My Struggles and Solutions for Dealing with Depression
Columns, Just Breathe...Compassionate Help for the PF Journey
Depression is a common problem for patients with pulmonary fibrosis. It makes sense; we are trying to process being ... Read more
August 7, 2017August 9, 2017
How It Feels To Be Rushed at a Store While Lugging an Oxygen Tank
Columns, Younger than 30: Living with IPF, a column by Charlene Marshall
I am still reflecting on an experience I had last week at the grocery store — one that, unfortunately, ... Read more
August 7, 2017August 7, 2017
Lung Stem Cells Close to Treating IPF, Other Lung Fibrosis Diseases, Say N.C. Researchers
News
Researchers at two universities in North Carolina have developed a new method to expand stem cells isolated from patient’s ... Read more
August 5, 2017August 5, 2017
Senolytic Drugs May Offer New IPF Therapy Options
News
Recent studies have shown that idiopathic pulmonary fibrosis (IPF) may be caused by senescence, a cellular aging process. Now, ... Read more

August 16, 2017August 16, 2017

Pulmonary Fibrosis Foundation Plans Inaugural PFF Walk in Chicago to Honor PF Awareness Month

The Chicago-based Pulmonary Fibrosis Foundation (PFF) will hold its inaugural PFF Walk on Sept. 9 to mark PF Awareness Month. More than 400 individuals and 80 teams from across the United States ... Read more

August 15, 2017August 15, 2017

IPF Catalyst Challenge Offers $1 Million Prize to Help Patients

Columns, Just Breathe...Compassionate Help for the PF Journey

I recently learned of a competition for innovators and entrepreneurs in the tech, healthcare, and scientific research communities to help those living with pulmonary fibrosis. It’s called the $1 ... Read more

August 14, 2017August 11, 2017

Patient as Self-Advocate: It Seems Impossible to Keep Up

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

As a patient living with idiopathic pulmonary fibrosis (IPF), I am extremely grateful to the researchers, doctors, health advocates, and other professionals dedicated to enhancing the quality of life ... Read more

August 14, 2017August 14, 2017

Galapagos Therapy GLPG1690 Excels in Phase 2 IPF Trial, Spurring Further Development

News

GLPG1690, an investigational therapy developed by Galapagos to treat idiopathic pulmonary fibrosis (IPF), prevented further lung decline in a Phase 2a trial, allowing the Belgian pharmaceutical firm to rapidly move forward with the ... Read more

August 11, 2017August 11, 2017

Experts Will Gather at Inaugural IPF Summit in Boston Aug. 21-23

News

Key leaders in the idiopathic pulmonary fibrosis therapy development industry, representing large pharma and biotech firms, academia and contract research organizations, will gather at the inaugural IPF Summit in ... Read more

August 10, 2017August 9, 2017

Lung Disease and Transplantation: The Harsh Realities

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

In previous columns, I have alluded to the world of lung diseases and organ transplantation as one that is unique and very different from the life that most people ... Read more

August 10, 2017August 10, 2017

FibroGen Shares Positive Results of Phase 2 Trial of Investigational Therapy Pamrevlumab

Esbriet, News

A Phase 2 trial testing the investigational therapy pamrevlumab (FG-3019) in patients with idiopathic pulmonary fibrosis (IPF) has shown positive and encouraging results, FibroGen, the drug’s developer, announced. In addition, combining ... Read more

August 9, 2017August 9, 2017

Three Lakes Partners Launches $1 Million ‘IPF Catalyst Challenge’ Competition

News

Three Lakes Partners, a venture philanthropy organization that finances research in idiopathic pulmonary fibrosis (IPF), has launched its $1 million IPF Catalyst Challenge — a competition to fund the most promising ideas in ... Read more

August 8, 2017August 8, 2017

My Struggles and Solutions for Dealing with Depression

Columns, Just Breathe...Compassionate Help for the PF Journey

Depression is a common problem for patients with pulmonary fibrosis. It makes sense; we are trying to process being diagnosed with this disease, and its effects on us now ... Read more

August 7, 2017August 9, 2017

How It Feels To Be Rushed at a Store While Lugging an Oxygen Tank

Columns, Younger than 30: Living with IPF, a column by Charlene Marshall

I am still reflecting on an experience I had last week at the grocery store — one that, unfortunately, is common for other patients, too. Several months after being ... Read more

August 7, 2017August 7, 2017

Lung Stem Cells Close to Treating IPF, Other Lung Fibrosis Diseases, Say N.C. Researchers

News

Researchers at two universities in North Carolina have developed a new method to expand stem cells isolated from patient’s lung biopsies. A team led by Dr. Jason Lobo, assistant ... Read more

August 5, 2017August 5, 2017

Senolytic Drugs May Offer New IPF Therapy Options

News

Recent studies have shown that idiopathic pulmonary fibrosis (IPF) may be caused by senescence, a cellular aging process. Now, a team of German researchers have successfully counteracted this mechanism ... Read more